142
Participants
Start Date
September 12, 2017
Primary Completion Date
September 6, 2022
Study Completion Date
September 6, 2022
LNA043
LNA043 intra-articular injection
Placebo
Placebo intra-articular injection
Novartis Investigative Site, Hvidovre
Novartis Investigative Site, Philadelphia
Novartis Investigative Site, Mladá Boleslav
Novartis Investigative Site, Miami Lakes
Novartis Investigative Site, Sunrise
Novartis Investigative Site, Tampa
Novartis Investigative Site, Pardubice
Novartis Investigative Site, Chicago
Novartis Investigative Site, St Louis
Novartis Investigative Site, Brno
Novartis Investigative Site, Boise
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, La Mesa
Novartis Investigative Site, Sacramento
Novartis Investigative Site, Kladno
Novartis Investigative Site, Kolín
Novartis Investigative Site, Prague
Novartis Investigative Site, Aarhus C
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY